Vimarsana
Biggest News Aggregation in the World

Ad26 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ad26. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ad26 Today - Breaking & Trending Today

Failure to launch: Sahpra rejects Sputnik V Covid-19 vaccine over HIV concerns - Vimarsana News

Failure to launch: Sahpra rejects Sputnik V Covid-19 vaccine over HIV concerns

The South African Health Products Regulatory Authority has not approved the Sputnik V vaccine because of concerns that it might lead to higher HIV infection rates among vaccinated males.

Failure to launch: Sahpra rejects Sputnik V Covid-19 vaccine over HIV concerns - Vimarsana News

Failure to launch: Sahpra rejects Sputnik V Covid-19 vaccine over HIV concerns

The South African Health Products Regulatory Authority has not approved the Sputnik V vaccine due to concerns that it might lead to higher HIV infection rates among vaccinated males.

Why Johnson & Johnson's Covid-19 Vaccine Is Generating A Lot Of Interest - Vimarsana News

Why Johnson & Johnson's Covid-19 Vaccine Is Generating A Lot Of Interest

Why Johnson & Johnson's Covid-19 vaccine is generating a lot of interest Initial reports indicate the vaccine elicits a very good response. The single-dose vaccine can prove to be a gamechanger, especially in a country with a large population, such as India, where two doses will consume tremendous resources January 18, 2021 / 05:11 PM IST With Johnson & Johnson (J&J)'s COVID-19 vaccine Phase-3 clinical trial data expected to be announced before the end of January, followed by an application for Emergency Use Authorization in the US and other countries, another vaccine may soon  become av...